BIO-TECHNE Corp Quarterly Liabilities and Equity in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
BIO-TECHNE Corp quarterly Liabilities and Equity history and growth rate from Q2 2010 to Q2 2024.
  • BIO-TECHNE Corp Liabilities and Equity for the quarter ending June 30, 2024 was $2.7B, a 2.47% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.7B +$65.2M +2.47% Jun 30, 2024 10-K 2024-08-22
Q1 2024 $2.72B +$121M +4.67% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $2.73B +$367M +15.5% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $2.76B +$405M +17.2% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.64B +$344M +15% Jun 30, 2023 10-K 2024-08-22
Q1 2023 $2.6B +$300M +13% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $2.36B +$58.6M +2.54% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $2.35B +$80.5M +3.55% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.29B +$31.8M +1.41% Jun 30, 2022 10-K 2023-08-23
Q1 2022 $2.3B +$215M +10.3% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.3B +$237M +11.5% Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $2.27B +$217M +10.6% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $2.26B +$235M +11.6% Jun 30, 2021 10-K 2022-08-24
Q1 2021 $2.08B +$85.6M +4.28% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $2.07B +$69.5M +3.48% Dec 31, 2020 10-Q 2021-02-08
Q3 2020 $2.05B +$128M +6.65% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $2.03B +$143M +7.6% Jun 30, 2020 10-K 2021-08-25
Q1 2020 $2B +$126M +6.75% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $2B +$154M +8.33% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 $1.93B +$52.8M +2.82% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $1.88B +$291M +18.3% Jun 30, 2019 10-K 2020-08-26
Q1 2019 $1.87B +$255M +15.8% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $1.84B +$289M +18.6% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $1.87B +$345M +22.6% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $1.59B +$35M +2.25% Jun 30, 2018 10-K/A 2019-11-06
Q1 2018 $1.62B +$84.4M +5.5% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $1.56B +$35.4M +2.33% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $1.53B +$9.9M +0.65% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.56B +$429M +37.9% Jun 30, 2017 10-K 2018-08-27
Q1 2017 $1.53B +$412M +36.7% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $1.52B +$387M +34.1% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $1.52B +$389M +34.5% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.13B +$66.2M +6.23% Jun 30, 2016 10-K 2017-09-07
Q1 2016 $1.12B +$17.6M +1.6% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $1.13B +$14.5M +1.29% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $1.13B +$110M +10.8% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $1.06B +$201M +23.3% Jun 30, 2015 10-K 2016-08-29
Q1 2015 $1.1B +$274M +33% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $1.12B +$317M +39.5% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $1.02B +$239M +30.7% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $862M +$84.4M +10.8% Jun 30, 2014 10-K 2015-08-31
Q1 2014 $831M +$70.3M +9.24% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $802M +$77.6M +10.7% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 $779M +$66.7M +9.35% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $778M +$58.8M +8.17% Jun 30, 2013 10-K 2014-08-29
Q1 2013 $760M +$76.3M +11.1% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $725M +$100M +16.1% Dec 31, 2012 10-Q 2013-02-11
Q3 2012 $713M +$84.2M +13.4% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $719M +$102M +16.5% Jun 30, 2012 10-K 2013-08-29
Q1 2012 $684M +$101M +17.4% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $624M +$68.6M +12.4% Dec 31, 2011 10-Q 2012-02-07
Q3 2011 $628M +$88.8M +16.5% Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $618M +$98.9M +19.1% Jun 30, 2011 10-K 2012-08-29
Q1 2011 $583M Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $556M Dec 31, 2010 10-Q 2011-02-09
Q3 2010 $540M Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $519M Jun 30, 2010 10-K 2011-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.